Astemizole
RESPIRATORY SYSTEM
Also known as: astemisan, hismanal, histazol, R 43 512
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Astemizole is a drug catalogued in DrugCentral. It was first approved by the FDA in 1988. DrugCentral lists 61 molecular targets, including KCNH2, FNTA|FNTB and HRH1. Recorded indications include Allergic conjunctivitis, Allergic rhinitis, Chronic idiopathic urticaria and Sneezing.
- Molecular targets: KCNH2, FNTA|FNTB, HRH1 and HTR2A (61 listed in DrugCentral).
- Indications: Allergic conjunctivitis, Allergic rhinitis, Chronic idiopathic urticaria and Sneezing.
- ATC code: R06AX11 (Other antihistamines for systemic use).
- Molecular formula: C28H31FN4O; molecular weight 458.58 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (4)
- Allergic conjunctivitis
- Allergic rhinitis
- Chronic idiopathic urticaria
- Sneezing
Off-label uses (1)
- Urticaria
Mechanism & targets
Molecular targets (61)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 | KCNH2 | unknown | IC50 9.05 |
| Protein farnesyltransferase | FNTA|FNTB | unknown | IC50 8.70 |
| Histamine H1 receptor | HRH1 | antagonist | A2 8.58 |
| 5-hydroxytryptamine receptor 2A | HTR2A | unknown | Ki 8.25 |
| 5-hydroxytryptamine receptor 2B | HTR2B | unknown | Ki 8.13 |
| Alpha-1D adrenergic receptor | ADRA1D | unknown | Ki 8.00 |
| Alpha-1A adrenergic receptor | Adra1a | unknown | IC50 7.62 |
| 5-hydroxytryptamine receptor 2C | HTR2C | unknown | Ki 7.03 |
| Alpha-1B adrenergic receptor | Adra1b | unknown | Ki 7.02 |
| Transmembrane protein 97 | TMEM97 | unknown | Ki 7.02 |
| 5-hydroxytryptamine receptor 3A | HTR3A | unknown | Ki 7.02 |
| D(3) dopamine receptor | DRD3 | unknown | Ki 6.83 |
| Muscarinic acetylcholine receptor M3 | CHRM3 | unknown | Ki 6.75 |
| Membrane-associated progesterone receptor component 1 | Pgrmc1 | unknown | Ki 6.73 |
| Potassium voltage-gated channel subfamily H member 1 | KCNH1 | blocker | IC50 6.70 |
| Muscarinic acetylcholine receptor M1 | CHRM1 | unknown | Ki 6.59 |
| Muscarinic acetylcholine receptor M4 | CHRM4 | unknown | Ki 6.59 |
| Alpha-2C adrenergic receptor | ADRA2C | unknown | Ki 6.54 |
| 5-hydroxytryptamine receptor 1A | HTR1A | unknown | Ki 6.36 |
| Muscarinic acetylcholine receptor M2 | CHRM2 | unknown | Ki 6.30 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1988-12-31 | FDA | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
R06AX11 | RESPIRATORY SYSTEM › ANTIHISTAMINES FOR SYSTEMIC USE › ANTIHISTAMINES FOR SYSTEMIC USE › Other antihistamines for systemic use |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Astemizole is on its molecule page.
| Molecular formula | C28H31FN4O |
|---|---|
| Molecular weight | 458.58 g/mol |
| CAS number | 68844-77-9 |
| InChIKey | GXDALQBWZGODGZ-UHFFFAOYSA-N |
| PubChem CID | 2247 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Astemizole used for?
DrugCentral lists the following indications for Astemizole: Allergic conjunctivitis, Allergic rhinitis, Chronic idiopathic urticaria and Sneezing.
How does Astemizole work?
Its molecular targets in DrugCentral include KCNH2, FNTA|FNTB, HRH1 (antagonist) and HTR2A.
When was Astemizole first approved?
Astemizole was first approved by the FDA in 1988.
What is the chemical formula of Astemizole?
Astemizole has the molecular formula C28H31FN4O and a molecular weight of 458.58 g/mol.
Browse: all drugs starting with A · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 249 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL296419 — compound record and bioactivity
- PubChem CID 2247 — chemical identifiers
- DrugBank DB00637 — drug record
- FDA UNII 7HU6337315 — substance identity
- DailyMed: FDA labels for Astemizole — current prescribing information (label search)
- UniProt Q12809 (KCNH2) — target protein
- UniProt P35367 (HRH1) — target protein
- UniProt P28223 (HTR2A) — target protein
- UniProt P41595 (HTR2B) — target protein
- UniProt P25100 (ADRA1D) — target protein
- UniProt P28335 (HTR2C) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.